Author | Efficacy determination | Adverse reactions | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DCR | ACT (minutes) | ATIPT (days) | CFR | Hypotension incidence | ||||||||||||
Propofol | Barbiturates | Propofol | Barbiturates | Propofol | Barbiturates | Propofol | Barbiturates | Propofol | Barbiturates | |||||||
n/N | % | n/N | % | n/N | % | n/N | % | n/N | % | n/N | % | |||||
van Gestel JP [14] | 14/22 | 64 | 11/20 | 55 | – | – | – | – | 2/22 | 9 | 8/20 | 40 | – | – | – | – |
Xiuquan F [12] | 7/9 | 77.7 | 4/9 | 44.4 | 3.71 ± 1.1 | 116 ± 31 | 2 ± 0.08 | 6 ± 0.31 | 5/9 | 66.6 | 6/9 | 55.5 | 7/9 | 77.7 | 6/9 | 66.6 |
Zengming W [11] | 6/7 | 85.7 | 6/7 | 85.7 | 5.62 ± 2.1 | 52 ± 17 | 3 ± 0.12 | 6 ± 0.27 | 1/7 | 14.3 | 1/7 | 14.4 | – | – | – | – |
Rossetti AO [15] | 6/14 | 43 | 2/9 | 22 | – | – | 4 | 13.5 | 6/14 | 43 | 3/9 | 33 | 7/14 | 50 | 5/9 | 55 |
Xiang C [13] | 8/9 | 88.8 | 8/9 | 88.8 | 5.58 ± 2.51 | 51.91 ± 2.49 | 3.01 ± 0.11 | 6.03 ± 0.19 | 1/9 | 11.1 | 1/9 | 11.1 | – | – | – | – |
Chunfen Z [17] | 44/45 | 97.7 | 37/45 | 82.2 | 15.51 ± 1.41 | 24.39 ± 2.77 | 2.62 ± 1.21 | 3.61 ± 2.59 | – | – | – | – | – | – | – | – |
Linzhi C [16] | 22/28 | 78.57 | 11/28 | 39.28 | 3.78 ± 1.1 | 52.6 ± 17.94 | – | – | 18/28 | 64.28 | 19/28 | 67.85 | 15/28 | 53.57 | 17/28 | 60.71 |